Vertaling van "recognise the risks of " (Nederlands → Frans) :

With a previous attempted suicide constituting the most important risk factor for a renewed attempt and with a minority of patients seeking professional help after a first attempt (according to the WHO, only one in four is admitted to hospital), it is absolutely vital that as many health professionals as possible (doctors, specialists, pharmacists, home care nurses, etc) should receive adequate training to recognise the risks of suicide and refer the patient to the appropriate health professional.
Si une tentative de suicide antérieure est le facteur de risque le plus important pour une nouvelle tentative de suicide, et si une minorité de patients font appel à l’aide professionnelle après une première tentative (seulement 1 sur 4 est pris en charge par le milieu hospitalier selon l’OMS), c’est une condition absolue qu’un maximum de prestataires de soins (médecins, spécialistes, pharmaciens, infirmières à domicile, etc) soient formés de façon adéquate pour reconnaître les risques de suicide et pour orienter vers le prestataire de soins professionnel adéquat.

The roles that pharmacists could play in this issue are: the ability to recognise risk factors such as a previous attempted suicide or the abusive use of medication, referring patients to health professionals when suspecting the early stages of a depression, and also to a certain extent following-up compliance and providing information on the side effects of the medicine.
Les rôles qui pourraient être attribués aux pharmaciens dans la problématique sont: savoir reconnaître les facteurs de risque comme une tentative de suicide antérieure ou l’abus de médicaments problématique, l’orientation vers des intervenants en cas de soupçon de début de dépression, et dans une certaine mesure également, le suivi de la compliance et l’information sur les effets secondaires des médicaments.

It follows that, as regards children and teenagers, it is of crucial importance that the health professional in charge of the patient be thoroughly experienced and trained to recognise the early signs of depression, and therefore also the symptoms of a risk of suicide, in time.
Dès lors, chez les enfants et les adolescents, il est primordial que le professionnel qui prend en charge le patient soit particulièrement averti et formé pour dépister à temps les signes précoces de dépression et a fortiori les symptômes de risque suicidaire.

Therefore, not including tiredness as one of the symptoms to be looked for during the diagnosis could result in there being a risk of failing to recognise the depression.
Il pourrait donc y avoir un risque de non-reconnaissance de la dépression si la fatigue ne fait pas partie des symptômes recherchés lors du diagnostic.

Recognising high-risk individuals and situations at an early stage: identifying certain (explicit, ambiguous or implicit) warning signs, having environmental factors under control, examining the indicator for the evolution of the suicidal thoughts provide real means for preventing suicide.
L’identification précoce des sujets et situations à risque: la reconnaissance de certains signes (explicites, ambigus ou implicites), le contrôle des facteurs environnementaux, l’exploration de l’indicateur d’évolution de l’idée suicidaire autorisent de réelles possibilités de prévention.

There is a risk that a depression is put down to the mourning process and is thus not recognised as such.
Le risque existe qu’une dépression soit attribuée à un travail de deuil et n’est donc pas reconnue.

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.

To ensure the population the optimal use of the medicines and health products they need, the FAMHP’s team manages, in a recognised, effective and responsible manner, all aspects of this area in consultation with all relevant parties in the health sector and the other national and international authorities.
To ensure the population the optimal use of the medicines and health products they need, the FAMHP’s team manages, in a recognised, effective and responsible manner, all aspects of this area in consultation with all relevant parties in the health sector and the other national and international authorities.

The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.
The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.

Even though there now are classifications available that allow the clinical identification of different types of depression, it still remains a fact that it is difficult to recognise one in care practice, especially in primary health care, with there being numerous ways in which this pathology can present itself (masked depression, depression that manifests itself through diffuse and persistent somatic signs…).
S’il existe aujourd’hui des classifications permettant d’identifier les différents types de dépression sur le plan clinique, il n’en reste pas moins vrai qu’en pratique de soin et en particulier en première ligne, des repérages restent difficiles au vu des travestissements de cette pathologie (dépression masquée, dépression se manifestant par des signes somatiques diffus et persistants…).